| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 153.111 | 160.829 | 169.540 | 213.237 | 289.689 | 256.188 | 362.384 | 634.971 | 637.112 | 732.406 |
| Total Income - EUR | 153.112 | 160.831 | 169.542 | 213.241 | 290.246 | 256.810 | 363.619 | 636.044 | 648.708 | 741.721 |
| Total Expenses - EUR | 119.296 | 126.758 | 130.354 | 136.548 | 145.058 | 127.991 | 160.817 | 168.733 | 213.704 | 234.320 |
| Gross Profit/Loss - EUR | 33.816 | 34.073 | 39.189 | 76.693 | 145.188 | 128.820 | 202.802 | 467.311 | 435.005 | 507.401 |
| Net Profit/Loss - EUR | 28.375 | 28.902 | 37.051 | 74.561 | 142.286 | 126.858 | 199.238 | 461.455 | 418.948 | 432.293 |
| Employees | 16 | 19 | 10 | 11 | 11 | 8 | 10 | 10 | 10 | 11 |
Check the financial reports for the company - Homeomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.508 | 9.561 | 7.598 | 9.782 | 14.210 | 10.735 | 9.331 | 10.135 | 10.260 | 11.254 |
| Current Assets | 26.984 | 37.013 | 45.736 | 82.479 | 154.371 | 203.135 | 213.921 | 460.477 | 428.849 | 451.760 |
| Inventories | 0 | 7 | 317 | 0 | 0 | 0 | 0 | 0 | 0 | 23.893 |
| Receivables | 5.216 | 6.154 | 6.298 | 6.748 | 5.137 | 6.992 | 5.689 | 169.689 | 233.514 | 237.438 |
| Cash | 21.768 | 30.852 | 39.122 | 75.731 | 149.233 | 196.144 | 208.232 | 290.788 | 195.335 | 190.428 |
| Shareholders Funds | 28.456 | 28.982 | 37.130 | 74.638 | 142.362 | 205.534 | 199.311 | 461.528 | 419.021 | 432.365 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 9.036 | 17.592 | 16.204 | 17.622 | 26.319 | 8.336 | 23.941 | 9.084 | 20.089 | 30.649 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Homeomed Srl